Meloxicam is available as a generic medication [1]. The U.S. Food and Drug Administration (FDA) approves generic drugs that have the same active ingredient, dosage form, strength, and route of administration as brand-name drugs. They are also required to have the same safety and efficacy [2].
When can generic meloxicam be expected?
The U.S. patent for meloxicam expired, allowing for generic versions to be developed and marketed [3]. Specific patent expiration dates and exclusivity periods can be complex and vary by region and patent type. Information on patent expiries for meloxicam can be found on resources like DrugPatentWatch.com [3].
Who makes generic meloxicam?
Multiple pharmaceutical companies manufacture generic versions of meloxicam. These include companies such as Aurobindo Pharma, Chartwell Pharmaceuticals, and Sandoz, among others [1]. The availability of generics can lead to increased competition among manufacturers.
How does generic meloxicam compare to brand-name meloxicam?
Generic meloxicam is bioequivalent to the brand-name formulation, meaning it is absorbed and becomes available in the body at the same rate and to the same extent [2]. This ensures that generic meloxicam has the same therapeutic effect and safety profile as the original brand-name drug.
What are the uses of meloxicam?
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to treat the symptoms of osteoarthritis and rheumatoid arthritis in adults and children 2 years and older. It is also used to treat juvenile rheumatoid arthritis in children [4]. It works by reducing hormones that cause inflammation and pain in the body [4].